You are here

Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche raises 2017 outlook after H1 beat

CNBC

Thu, 07/27/17 - 10:02 am

Tags:

Roche, earnings

Biotechs Find Strength In Numbers In Treating Multiple Sclerosis

Investors Business Daily

Fri, 07/21/17 - 10:25 am

Tags:

MS, multiple sclerosis, Roche, Celgene, Novartis, Biogen, ozanimod, Gilenya, Ocrevus, Extavia

Diabetes drugmakers partner with mobile startups to boost patient engagement

Medical Marketing and Media

Fri, 07/21/17 - 10:03 am

Tags:

diabetes, mobile apps, patients, Novo Nordisk, Glooko, Roche, mySugr

Poor test results for Roche cloud growth prospects

Yahoo/Reuters

Wed, 07/19/17 - 09:54 am

Tags:

Roche, biosimilars, Rituxan, Herceptin, Avastin

5 Big Pharma Stocks With the Best Drug Pipelines

Motley Fool

Tue, 07/18/17 - 11:32 am

Tags:

Big Pharma, Roche, AstraZeneca, AbbVie, Gilead Sciences, JNJ

The biosimilar pack is growing around Roche’s all-star trio, looking to rip into a $21B franchise

Endpoints

Wed, 07/12/17 - 10:36 am

Tags:

Roche, biosimilars, Avastin, Herceptin, ABP 215, Amgen, MYL-14010, Mylan Labs, Rituxan

Shire blasts rival Roche for its “misleading” case for hemophilia trailblazer emicizumab

Motley Fool

Sun, 07/9/17 - 07:39 pm

Tags:

Shire, Roche, hemophilia, emicizumab

Why Drugmakers Aren’t Sweating the Next Wave of Patent Losses

Bloomberg

Sat, 07/8/17 - 10:18 am

Tags:

patents, Roche, Sanofi, Eli Lilly, patent cliff

Prescribed Reading: I/O is the only game in town

BioPharma Dive

Sat, 07/8/17 - 10:02 am

Tags:

immuno-oncology, Celgene, BeiGene, Endo International, Opana ER, Novartis, Orkambi, Vertex Pharmaceuticals, Merck, Bristol-Myers Squibb, Roche, Opdivo, Keytruda, Orencia

Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul

Bloomberg

Fri, 07/7/17 - 10:31 am

Tags:

rare disease, healthcare reform, Shire, Jazz Pharmaceuticals, Sanofi, Roche, Biogen, Alexion, Vertex Pharmaceuticals

Sanofi and Alnylam plunge into PhIII with a rival to Roche’s top hemophilia drug

Endpoints

Fri, 07/7/17 - 10:22 am

Tags:

Sanofi, Alnylam, clinical trials, fitusiran, hemophilia, Roche, emicizumab

Industry paid $8.2B to docs, hospitals last year

BioPharma Dive

Wed, 07/5/17 - 07:27 pm

Tags:

physicians, physician payments, Roche, Novartis, Pfizer

PTC and Roche report solid data for Spinraza rival

BioPharma Dive

Wed, 07/5/17 - 06:55 pm

Tags:

PTC Therapeutics, Roche, Spinraza, Biogen, RG7916, SMA, spinal muscular atrophy

Roche buys mySugr diabetes app

Drug Delivery Business News

Sat, 07/1/17 - 09:23 am

Tags:

Roche, mySugr, mobile apps, diabetes, devices

The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)

Motley Fool

Fri, 06/30/17 - 11:06 am

Tags:

prescription data, Sanofi, Lantus, Roche, Herceptin, Avastin, Celgene, Revlimid, JNJ, Merck, Remicade, Biogen, Rituxan, Amgen, Enbrel, Gilead Sciences, Harvoni, AbbVie, Humira

Novartis scores second biosimilar approval in two weeks

BioPharma Dive

Thu, 06/29/17 - 09:43 am

Tags:

Novartis, biosimilars, Enbrel, Europe, Sandoz, Erelzi, Roche, Rituxan

Roche’s hemophilia drug slashes bleeding rate, boosting blockbuster projections — but doubts on safety linger

Endpoints

Mon, 06/26/17 - 09:54 am

Tags:

Roche, hemophilia A, ACE910, emicizumab, clinical trials

Roche's Ocrevus racks up more positive MS data in relapsing and primary progressive forms

Fierce Pharma

Sat, 06/24/17 - 09:14 am

Tags:

Roche, Ocrevus, MS, multiple sclerosis

FDA says yes to rapid-acting Rituxan

BioPharma Dive

Fri, 06/23/17 - 11:23 am

Tags:

FDA, Roche, Rituxan Hycela, refractory follicular lymphoma, CLL, diffuse large B-cell lymphoma

Novartis wins another biosimilar round with an OK for its Rituxan copycat

Endpoints

Mon, 06/19/17 - 03:16 pm

Tags:

Novartis, biosimilars, Rituxan, Roche, Sandoz

Pages

last 30 twitter posts